11/26
02:11 pm
lfmd
LifeMD (NASDAQ:LFMD) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
LifeMD (NASDAQ:LFMD) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/24
05:08 pm
lfmd
LifeMD (NASDAQ:LFMD) was given a new $8.00 price target on by analysts at Loop Capital.
Low
Report
LifeMD (NASDAQ:LFMD) was given a new $8.00 price target on by analysts at Loop Capital.
11/24
08:00 am
lfmd
LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME’s America’s Growth Leaders of 2026
Low
Report
LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME’s America’s Growth Leaders of 2026
11/22
07:57 am
lfmd
LifeMD (NASDAQ:LFMD) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
LifeMD (NASDAQ:LFMD) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
11/22
07:45 am
lfmd
LifeMD: WorkSimpli Divestment Creates Virtual Care Pure Play [Seeking Alpha]
Low
Report
LifeMD: WorkSimpli Divestment Creates Virtual Care Pure Play [Seeking Alpha]
11/22
02:11 am
lfmd
Low
Report
11/20
10:33 pm
lfmd
LifeMD (LFMD): Valuation in Focus After Earnings Miss, Guidance Cut, and Telehealth Shift [Yahoo! Finance]
Medium
Report
LifeMD (LFMD): Valuation in Focus After Earnings Miss, Guidance Cut, and Telehealth Shift [Yahoo! Finance]
11/19
06:37 pm
lfmd
Looking at the Narrative for LifeMD as Analyst Sentiment Shifts on Recent Developments [Yahoo! Finance]
Medium
Report
Looking at the Narrative for LifeMD as Analyst Sentiment Shifts on Recent Developments [Yahoo! Finance]
11/19
11:35 am
lfmd
LifeMD (NASDAQ:LFMD) had its price target lowered by analysts at HC Wainwright from $13.00 to $9.00. They now have a "buy" rating on the stock.
Low
Report
LifeMD (NASDAQ:LFMD) had its price target lowered by analysts at HC Wainwright from $13.00 to $9.00. They now have a "buy" rating on the stock.
11/19
10:19 am
lfmd
LifeMD (NASDAQ:LFMD) had its price target lowered by analysts at KeyCorp from $12.00 to $8.00. They now have an "overweight" rating on the stock.
Low
Report
LifeMD (NASDAQ:LFMD) had its price target lowered by analysts at KeyCorp from $12.00 to $8.00. They now have an "overweight" rating on the stock.
11/19
09:37 am
lfmd
LifeMD (NASDAQ:LFMD) had its price target lowered by analysts at Mizuho from $8.00 to $6.00. They now have a "neutral" rating on the stock.
Low
Report
LifeMD (NASDAQ:LFMD) had its price target lowered by analysts at Mizuho from $8.00 to $6.00. They now have a "neutral" rating on the stock.
11/18
07:06 pm
lfmd
Why LifeMD (LFMD) Is Down 7.8% After Trimming Guidance Post-WorkSimpli Exit and Refocus [Yahoo! Finance]
Low
Report
Why LifeMD (LFMD) Is Down 7.8% After Trimming Guidance Post-WorkSimpli Exit and Refocus [Yahoo! Finance]
11/18
01:13 pm
lfmd
LifeMD (NASDAQ:LFMD) had its price target lowered by analysts at Lake Street Capital from $14.00 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
LifeMD (NASDAQ:LFMD) had its price target lowered by analysts at Lake Street Capital from $14.00 to $8.00. They now have a "buy" rating on the stock.
11/18
12:20 pm
lfmd
LifeMD (NASDAQ:LFMD) had its price target lowered by analysts at B. Riley from $12.00 to $10.00. They now have a "buy" rating on the stock.
Medium
Report
LifeMD (NASDAQ:LFMD) had its price target lowered by analysts at B. Riley from $12.00 to $10.00. They now have a "buy" rating on the stock.
11/18
05:49 am
lfmd
Biggest stock movers Tuesday: OWL, AXTA, and more [Seeking Alpha]
High
Report
Biggest stock movers Tuesday: OWL, AXTA, and more [Seeking Alpha]
11/18
02:25 am
lfmd
LifeMD, Inc. (LFMD) Q3 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
LifeMD, Inc. (LFMD) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/18
12:04 am
lfmd
LifeMD Inc (LFMD) Q3 2025 Earnings Call Highlights: Strong Telehealth Growth Amidst Competitive ... [Yahoo! Finance]
High
Report
LifeMD Inc (LFMD) Q3 2025 Earnings Call Highlights: Strong Telehealth Growth Amidst Competitive ... [Yahoo! Finance]
11/17
08:50 pm
lfmd
LifeMD outlines $192M-$193M 2025 revenue target amid margin shifts and expansion into women's and behavioral health [Seeking Alpha]
High
Report
LifeMD outlines $192M-$193M 2025 revenue target amid margin shifts and expansion into women's and behavioral health [Seeking Alpha]
11/17
04:41 pm
lfmd
LifeMD Reports Third Quarter 2025 Results [Yahoo! Finance]
Medium
Report
LifeMD Reports Third Quarter 2025 Results [Yahoo! Finance]
11/17
04:05 pm
lfmd
LifeMD Reports Third Quarter 2025 Results
Medium
Report
LifeMD Reports Third Quarter 2025 Results
11/17
08:12 am
lfmd
LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk [Yahoo! Finance]
Medium
Report
LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk [Yahoo! Finance]
11/17
08:00 am
lfmd
LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk
High
Report
LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk
11/16
05:35 pm
lfmd
LifeMD Q3 2025 Earnings Preview [Seeking Alpha]
Low
Report
LifeMD Q3 2025 Earnings Preview [Seeking Alpha]
11/10
08:00 am
lfmd
LifeMD to Participate in the BTIG Digital Health Forum
Medium
Report
LifeMD to Participate in the BTIG Digital Health Forum
11/5
05:15 pm
lfmd
LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17
Medium
Report
LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17